Published in:
01-10-2016 | Original Article
Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System
Published in: Digestive Diseases and Sciences | Issue 10/2016
Login to get accessAbstract
Background and Aim
This study aimed to develop and validate a risk score model to estimate the probability of a metachronous advanced colorectal neoplasm (ACRN) at surveillance colonoscopy.
Methods
A retrospective analysis of a prospectively obtained database of 11,042 asymptomatic subjects who underwent surveillance colonoscopy after a screening colonoscopy was conducted. Subjects were randomly divided into derivation (n = 7730) and validation sets (n = 3312). From the derivation cohort, risk factors for a metachronous ACRN were identified by a multivariable analysis. Risk points were allocated to each risk factor based on the hazard ratio to develop the Metachronous Advanced colorectal neoplasm Prediction Scoring (MAPS) model, the performance of which was assessed in the validation cohort.
Results
In the derivation cohort, age, male, sessile serrated adenoma/polyp, and a high-risk CRN (ACRN or ≥3 adenomas) at screening colonoscopy were independent risk factors for a metachronous ACRN. These variables were incorporated into the MAPS model, and the risk score ranged 0–17 (high MAPS risk arbitrarily defined as 10–17). At the 3-year surveillance colonoscopy, ACRN was found in 5.1 % of the high MAPS risk group versus 3.9 % of the high-risk CRN group. The colonoscopy number needed to detect one metachronous ACRN at the 3-year surveillance was 19.5 (95 % CI 11.7–33.2) for the high MAPS risk group versus 25.8 (95 % CI 15.4–44.0) for the high-risk CRN group. These findings were similarly confirmed in the validation cohort.
Conclusions
Our MAPS model based on clinical and colonoscopic parameters effectively predicts the risk of a metachronous ACRN.